Track record. A lot of the therapeutic proposals for COVID-19 are already connected with adverse outcomes, including the possibility of QT interval prolongation and torsades de pointes (TdP). The objective was to find out using medication which has a threat of QT interval prolongation in 21 clinics/hospitals in Colombia https://directivepublications.org/journal-of-vascular-medicine/